Framingham Risk Score for Hard Coronary Heart Disease

ورودی‌های بالینی بیمار

حداقل ۳۰ — حداکثر ۷۹ • واحد: years

حداقل ۱۰۰ — حداکثر ۴۰۰ • واحد: mg/dL

حداقل ۲۰ — حداکثر ۱۰۰ • واحد: mg/dL

حداقل ۹۰ — حداکثر ۲۰۰ • واحد: mmHg

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
risk percentage
—%
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–5
  • Borderline Risk5–10
  • Intermediate Risk10–20
  • High Risk20–100
Direct Clinical Answer

The Framingham Risk Score for Hard Coronary Heart Disease calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Estimates 10-year risk of myocardial infarction in patients aged 30-79 with no history of coronary heart disease or diabetes

Clinical Indication

The Framingham Risk Score for Hard Coronary Heart Disease is indicated for bedside clinical practice to support Estimates 10-year risk of myocardial infarction in patients aged 30-79 with no history of coronary heart disease or diabetes. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Not recommended for patients with diabetes or known coronary heart disease.

Formula & Variables:

Gender-specific logarithmic regression equation using age, cholesterol levels, blood pressure, smoking status, and treatment history

Input Parameters

NameTypeRequiredDescription
ageintegerYesPatient age in years(years)
sexstringYesPatient sex
total_cholesterolfloatYesTotal cholesterol level(mg/dL)
hdl_cholesterolfloatYesHDL cholesterol level(mg/dL)
systolic_bpintegerYesSystolic blood pressure(mmHg)
bp_treatmentstringYesCurrently taking blood pressure medication
smokingstringYesCurrent smoker

Score Interpretation & Guidance

RangeStageDescription
0–5Low RiskLow 10-year CHD risk
5–10Borderline RiskBorderline 10-year CHD risk
10–20Intermediate RiskIntermediate 10-year CHD risk
20–100High RiskHigh 10-year CHD risk

Evidence-Based References (EBM)

  • Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47. doi: 10.1161/01.cir.97.18.1837.DOI: 10.1161/01.cir.97.18.1837
  • D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579.DOI: 10.1161/CIRCULATIONAHA.107.699579
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. doi: 10.1001/jama.285.19.2486.DOI: 10.1001/jama.285.19.2486

Related calculators